Why the study?
Does atrial CMR-FT provide superior prognostic value for adverse events compared to LVEF and atrial volume in patients with Takotsubo syndrome?
Does atrial CMR-FT provide superior prognostic value for adverse events compared to LVEF and atrial volume in patients with Takotsubo syndrome?
Atrial CMR-FT identifies transient impairments in LA mechanics and may serve as a superior prognostic marker for adverse events in Takotsubo syndrome compared to traditional parameters like LVEF.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in Takotsubo beyond LVEF; leaves open prospective validation before clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Backhaus et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: